Past experience is not a current safety plan
Someone may remember using cannabis comfortably decades ago or have years of recent experience. That history is useful, but it cannot account for every change in health, medicines or products. Health Canada’s guidance for adults over 55 notes greater sensitivity and side-effect risk in some older adults, particularly when health conditions and other products are involved.
Age is not a verdict that a person cannot make a good decision. It is a reason to ask better questions about the present situation. What has changed since the last comfortable experience? What is the person trying to improve now? Is the current product similar to the one they remember?
Our guide to talking with your doctor about cannabis can help turn those questions into a conversation instead of a yes-or-no argument about cannabis in general.
Bring the entire medication list
Cannabis deserves to be part of the medication conversation even if it was obtained without a prescription. The FDA recommends keeping an up-to-date list of medicines, over-the-counter products, vitamins and supplements. Bring that list and the actual cannabis label, including ingredients, amounts and route, to your pharmacist or clinician.
Ask whether the combination raises concerns about sleepiness, dizziness or how particular medicines work. This is more useful than asking whether cannabis “interacts with anything.” Our medication and health overview introduces that broader issue, but a personal review needs the specific list.
CBD is not an exemption from this conversation. FDA information on CBD describes medication interactions and other possible side effects. Do not skip or reduce prescribed medicines on your own to make room for cannabis; ask the professional who manages them about the plan.
Think about balance before the difficult moment
Health Canada describes dizziness, drowsiness and changes in coordination as relevant cannabis effects. It also notes that blood pressure can fall with a change from sitting or lying down to standing. Those possibilities matter when someone needs to get to the bathroom, climb stairs or move around alone.
The CDC’s fall-prevention guidance recommends reviewing medicines that may cause dizziness or sleepiness, removing trip hazards and improving lighting. Apply that thinking to the everyday environment before a person is uncomfortable or unsteady. Keep ordinary walking aids accessible and avoid creating a situation where someone has to improvise their way through a dark room.
If a person has had a fall or a near miss, bring it into the health conversation. A lower pain score does not cancel an increased difficulty getting safely around the home.
Choose a meaningful goal, not a stronger product
Relief is easier to assess when it connects with something the person values. Perhaps the hope is to prepare a meal, enjoy a visit or sit comfortably through a family event. Let the person name that goal rather than assuming everyone wants the same outcome.
Compare the product’s actual THC amount, the route and the experience, not just a strain name or the strongest percentage. Our guide to understanding potency units explains why the label needs context. More intoxication is not evidence of more benefit, especially if it limits conversation, mobility or the next day’s routine.
There is no age-based dose in this article. A clinician who knows the person’s conditions and medicines can help assess whether a product is appropriate. Medical intent does not automatically make a high-THC preparation a good fit.
Timing can affect the whole day
The route matters for when effects appear and how long they may interfere with plans. Oral cannabis can take hours to show its full effects, so repeatedly adding more because nothing seems to be happening can create an unexpectedly difficult experience. Our comparison of edibles, smoking and oils explains the general timing differences.
Discuss responsibilities before use, including driving, preparing meals and managing medicines. Plan how help will be available if needed, while keeping the person involved in that plan. Avoid pairing a new product experience with a demanding activity simply because the package describes it as calming.
For someone who is having trouble reading labels or remembering what was used, simplify the record rather than relying on memory. Keep the original packaging and make the agreed plan easy to understand. If confusion is new, seek an assessment instead of assuming a better reminder system is the whole answer.
Support independence without taking over
Family members can help by asking what the person wants, what they have noticed and where support would be useful. “Would you like me to bring the label to the appointment?” leaves more room for choice than “I have decided what you should take.” Our article on helping a loved one who uses cannabis offers a compassionate starting point.
Respect consent and privacy. Do not give someone cannabis without their informed agreement, hide it in food or pressure them to try it because another relative felt better. If decision-making ability is in question, involve the care team and the appropriate decision maker rather than trying to resolve that through a product recommendation.
Shared responsibility also means communicating clearly between helpers. An assumption that someone else knows what was taken is not a reliable record. Keep the person’s preferences and the agreed support visible to everyone involved in their care.
Watch function as carefully as comfort
A short record can include the product, time, intended benefit and unwanted effects. Ask whether the person could do the activity they hoped to do, whether walking or conversation felt different and how the following morning went. Our guide to tracking cannabis benefits and side effects provides a simple structure.
Contact a clinician about concerning changes. For chest pain, serious breathing difficulty, loss of consciousness or sudden stroke-like symptoms, call 911. Do not explain away serious symptoms as being “just too high.” If there is uncertainty about a new effect, it is better to describe the product and timing honestly when seeking care.
The record should support decisions, not become a scorecard used against the person. If the hoped-for benefit does not outweigh the problems, reassessing the approach is care, not defeat.
Sources and further reading
- Health Canada: Health effects of cannabis on adults over 55, updated April 2026
- FDA: Five medication safety tips for older adults
- CDC: Preventing falls and hip fractures
- FDA: What to know about products containing cannabis or CBD
- CDC: Cannabis frequently asked questions, including route-specific risks
- CDC: Signs and symptoms of stroke and emergency action
- CDC: Heart attack symptoms and emergency action